MYC Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas (NCT01897012) | National Cancer Institute (NCI) | 2013-07-17 |
Track MYC Positive automatically
Every clearance here is in the API, with alerts when new ones post.